Atıf İçin Kopyala
Yekeduz E., Utkan G., ÜRÜN Y.
EUROPEAN JOURNAL OF CANCER, cilt.141, ss.92-104, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
141
-
Basım Tarihi:
2020
-
Doi Numarası:
10.1016/j.ejca.2020.09.028
-
Dergi Adı:
EUROPEAN JOURNAL OF CANCER
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, Agricultural & Environmental Science Database, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, MEDLINE, Veterinary Science Database
-
Sayfa Sayıları:
ss.92-104
-
Anahtar Kelimeler:
COVID-19, SARS-CoV-2, Cancer treatment, Chemotherapy, Immunotherapy, Targeted therapy, MORTALITY, RADIOTHERAPY, SARS-COV-2, INFECTIONS
-
Ankara Üniversitesi Adresli:
Evet
Özet
Background: The COVID-19 pandemic hit all over the world, and cancer patients are more vulnerable for COVID-19. The mortality rate may increase up to 25% in solid malignancies. In parallel to increased mortality rates among cancer patients, safety concerns regarding cancer treatment has increased over time. However, there were contradictory results for the cancer treatment during pandemic. In this study, we assessed the effect of cancer treatment on the severity of COVID-19.